Is Now a Good Time to Buy Ocugen?

·4 min read
Is Now a Good Time to Buy Ocugen?

In the coronavirus vaccine market, several players -- including Moderna and Pfizer -- are currently benefiting from a first-mover advantage. One of them is Ocugen (NASDAQ: OCGN), a company that partnered with India-based Bharat Biotech to develop and market a COVID-19 vaccine called Covaxin. Like many other meme stocks, shares of Ocugen have been highly volatile since the beginning of the year -- and a recent regulatory breakthrough in India sent the company's stock soaring through the roof.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting